151 related articles for article (PubMed ID: 20936377)
1. Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma.
Lu JW; Chang JG; Yeh KT; Chen RM; Tsai JJ; Hu RM
Med Oncol; 2011 Dec; 28 Suppl 1():S239-45. PubMed ID: 20936377
[TBL] [Abstract][Full Text] [Related]
2. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
4. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
5. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
6. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
7. UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Xu H; Yu H; Zhang X; Shen X; Zhang K; Sheng H; Dai S; Gao H
Int J Clin Exp Pathol; 2013; 6(4):711-7. PubMed ID: 23573318
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma.
Lu JW; Chang JG; Yeh KT; Chen RM; Tsai JJ; Su WW; Hu RM
Clin Transl Oncol; 2012 Apr; 14(4):287-93. PubMed ID: 22484636
[TBL] [Abstract][Full Text] [Related]
9. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
[TBL] [Abstract][Full Text] [Related]
10. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
11. Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.
Chen HL; OuYang HY; Le Y; Jiang P; Tang H; Yu ZS; He MK; Tang YQ; Shi M
Cancer Med; 2018 Nov; 7(11):5339-5350. PubMed ID: 30306706
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma.
Chen H; Jia WD; Li JS; Wang W; Xu GL; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB; Zhang CH; Wang YC
Med Oncol; 2011 Dec; 28 Suppl 1():S318-25. PubMed ID: 21128013
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.
Wachter DL; Kristiansen G; Soll C; Hellerbrand C; Breuhahn K; Fritzsche F; Agaimy A; Hartmann A; Riener MO
Histopathology; 2012 Jan; 60(2):278-86. PubMed ID: 22211286
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Poor Prognosis and Lower TPPP Gene Expression in Hepatocellular Carcinoma.
Inokawa Y; Sonohara F; Kanda M; Hayashi M; Nishikawa Y; Sugimoto H; Kodera Y; Nomoto S
Anticancer Res; 2016 Sep; 36(9):4639-45. PubMed ID: 27630306
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
[TBL] [Abstract][Full Text] [Related]
18. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis.
Lu JW; Chang JG; Yeh KT; Chen RM; Tsai JJ; Hu RM
Acta Histochem; 2011 Dec; 113(8):833-8. PubMed ID: 21272924
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]